| Surgery | Lifetime | 617 | US 336 | 99.42 |
| Cardiology and Cardiovascular Medicine | Lifetime | 420 | US 237 | 99.44 |
| Public, Environmental and Occupational Health | Lifetime | 884 | US 456 | 98.73 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 800 | US 420 | 97.14 |
| Surgery | 2021-2025 | 225 | US 88 | 98.62 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 655 | US 280 | 88.29 |
| Speech and Hearing | 2021-2025 | 169 | US 51 | 71.70 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 706 | US 284 | 64.88 |
| Cardiovascular Function and Risk Factors | Lifetime | 271 | US 160 | 99.47 |
| Cardiovascular Disease and Adiposity | Lifetime | 143 | US 83 | 99.19 |
| Lipoproteins and Cardiovascular Health | Lifetime | 161 | US 92 | 99.22 |
| Blood Pressure and Hypertension Studies | Lifetime | 248 | US 111 | 99.18 |
| Congenital Heart Disease Studies | Lifetime | 259 | US 152 | 98.82 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 223 | US 102 | 99.16 |
| Birth, Development, and Health | Lifetime | 442 | US 178 | 98.66 |
| Cardiovascular Health and Risk Factors | Lifetime | 91 | US 55 | 98.46 |
| Obesity, Physical Activity, Diet | Lifetime | 552 | US 239 | 98.72 |
| Cardiovascular Health and Disease Prevention | Lifetime | 368 | US 162 | 98.22 |
| Coronary Artery Anomalies | Lifetime | 440 | US 215 | 96.17 |
| Kawasaki Disease and Coronary Complications | Lifetime | 235 | US 77 | 95.07 |
| Lipid metabolism and disorders | Lifetime | 541 | US 204 | 94.66 |
| Child and Adolescent Health | Lifetime | 978 | US 512 | 93.29 |
| Pharmaceutical Economics and Policy | Lifetime | 824 | US 350 | 92.05 |
| Health and Medical Research Impacts | Lifetime | 800 | US 459 | 88.19 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 85 | US 40 | 97.78 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 391 | US 133 | 96.33 |
| Health and Medical Research Impacts | 2021-2025 | 37 | US 19 | 92.92 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 388 | US 98 | 91.80 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 583 | US 115 | 87.95 |
| Pharmaceutical Economics and Policy | 2021-2025 | 297 | US 113 | 85.93 |